Production (Stage)
Encompass Health Corporation
EHC
$118.90
$0.290.24%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.59% | 12.69% | 11.94% | 9.61% | 13.41% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.59% | 12.69% | 11.94% | 9.61% | 13.41% |
| Cost of Revenue | 7.06% | 11.46% | 11.26% | 10.16% | 12.79% |
| Gross Profit | 15.57% | 14.46% | 12.92% | 8.86% | 14.30% |
| SG&A Expenses | 4.67% | 3.13% | 6.88% | -7.17% | 12.24% |
| Depreciation & Amortization | 12.66% | 11.27% | 16.49% | 0.41% | 10.02% |
| Other Operating Expenses | 12.40% | 11.69% | 10.18% | 9.96% | 8.77% |
| Total Operating Expenses | 8.22% | 10.96% | 11.13% | 8.21% | 11.85% |
| Operating Income | 22.53% | 22.33% | 16.56% | 17.24% | 22.00% |
| Income Before Tax | 33.74% | 22.21% | 26.76% | 23.02% | 22.02% |
| Income Tax Expenses | 8.62% | 1.08% | 18.81% | 16.77% | 20.06% |
| Earnings from Continuing Operations | 40.61% | 28.37% | 28.86% | 24.75% | 22.57% |
| Earnings from Discontinued Operations | 61.54% | 104.71% | 46.15% | 0.00% | -30.00% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -71.10% | -37.46% | -38.43% | -25.58% | -2.73% |
| Net Income | 34.67% | 38.01% | 26.85% | 24.84% | 28.28% |
| EBIT | 22.53% | 22.33% | 16.56% | 17.24% | 22.00% |
| EBITDA | 20.12% | 19.35% | 16.54% | 12.48% | 18.85% |
| EPS Basic | 34.34% | 37.35% | 26.41% | 24.27% | 27.72% |
| Normalized Basic EPS | 12.77% | 15.08% | 21.42% | 21.55% | 38.85% |
| EPS Diluted | 34.79% | 36.93% | 25.97% | 23.73% | 26.65% |
| Normalized Diluted EPS | 13.65% | 14.76% | 21.08% | 20.99% | 37.64% |
| Average Basic Shares Outstanding | 0.70% | 0.50% | 0.40% | 0.40% | 0.40% |
| Average Diluted Shares Outstanding | -0.10% | 0.79% | 0.69% | 0.89% | 1.29% |
| Dividend Per Share | 13.33% | 13.33% | 13.33% | 0.00% | 0.00% |
| Payout Ratio | -0.16% | -0.17% | -0.21% | -0.20% | -0.21% |